In this webinar, Rico Buchli, PhD, shares how next-generation soluble HLA peptide discovery platforms can strengthen early immunotherapy R&D - from target identification and confirmation to receptor/drug validation and translational decision-making.
Human leukocyte antigen (HLA)-presented peptides define one of the most powerful target spaces in immunotherapy. By enabling access to intracellular and mutation-derived antigens, HLA-peptide complexes dramatically expand what can be targeted beyond conventional surface proteins.
Dr. Buchli, Chief Scientist at HLA Protein Technologies, shares how HLA-peptide workflows help teams select targets with higher confidence, reduce off-target risk, and de-risk programs earlier, with practical examples spanning oncology, infectious disease, and autoimmunity. Participants will connect HLA-peptide target evidence to multiple T-cell-directed therapeutic modalities, such as CAR-Ts, T-cell engagers, and vaccines. You will also leave with a clearer framework for building an HLA-peptide target strategy, what "good" looks like for validation, and where these tools accelerate go/no-go decisions.
Presenters
Rico Buchli
Dr. Rico Buchli is a leading expert in HLA biology and soluble HLA technology, with extensive experience in immunology and biochemistry. He has significantly contributed to developing HLA-based immunotherapy tools for oncology, infectious disease, and autoimmunity, authored peer-reviewed papers, and holds multiple international patents.
Sponsor
HLA Protein Technologies Inc.
Content Partners
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
